Founders Fund V Management, LLC Cyclo Therapeutics, Inc. Transaction History
Founders Fund V Management, LLC
- $21.7 Million
- Q1 2024
A detailed history of Founders Fund V Management, LLC transactions in Cyclo Therapeutics, Inc. stock. As of the latest transaction made, Founders Fund V Management, LLC holds 480,708 shares of CYTH stock, worth $581,656. This represents 3.08% of its overall portfolio holdings.
Number of Shares
480,708
Previous 480,708
-0.0%
Holding current value
$581,656
Previous $764,000
12.57%
% of portfolio
3.08%
Previous 89.88%
Shares
1 transactions
Others Institutions Holding CYTH
# of Institutions
22Shares Held
2.16MCall Options Held
0Put Options Held
0-
Epiq Capital Group, LLC San Francisco, CA854KShares$1.03 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA397KShares$479,9560.0% of portfolio
-
Geode Capital Management, LLC Boston, MA160KShares$193,2960.0% of portfolio
-
Founders Fund Vi Management, LLC San Francisco, CA110KShares$133,12757.89% of portfolio
-
State Street Corp Boston, MA39.5KShares$47,8310.0% of portfolio
About Cyclo Therapeutics, Inc.
- Ticker CYTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 8,439,440
- Market Cap $10.2M
- Description
- Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of...